Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Benekli

Showing results (51-60 of 61) with videos related to

Pageof 7
Sort By:
Journal of B.U.ON. : Official Journal of the Balkan Union of Oncology|July 27, 2010
Efficacy and toxicity of preoperative chemotherapy with docetaxel and epirubicin in locally advanced invasive breast cancerA O Kaya, U Coskun, S Buyukberber, et al.
Bone Marrow Transplantation|December 12, 2007
Intensive conditioning regimen of etoposide (VP-16), cyclophosphamide and carmustine (VCB) followed by autologous hematopoietic stem cell transplantation for relapsed and refractory Hodgkin's lymphomaM Benekli, S L Smiley, T Younis, et al.
Breast (Edinburgh, Scotland)|August 20, 2013
Phase II study of lapatinib in combination with vinorelbine in patients with HER2 positive recurrent or metastatic breast cancer: a multicentric Turkish Oncology Group (TOG) trialP Saip, Y Eralp, F Sen, et al.
Neoplasma|January 15, 2008
Xelox (capecitabine plus oxaliplatin) as neoadjuvant chemotherapy of unresectable liver metastases in colorectal cancer patientsU Coskun, S Buyukberber, E Yaman, et al.
Neoplasma|November 23, 2011
Gemcitabine and cisplatin combination chemotherapy in triple negative metastatic breast cancer previously treated with a taxane/anthracycline chemotherapy; multicenter experienceM Ozkan, V Berk, M A Kaplan, et al.
Journal of B.U.ON. : Official Journal of the Balkan Union of Oncology|January 22, 2013
Multiple primary malignant neoplasms: multi-center results from TurkeyN A Babacan, S Aksoy, B Cetin, et al.
Bone Marrow Transplantation|July 3, 2003
Effect of rituximab on peripheral blood stem cell mobilization and engraftment kinetics in non-Hodgkin's lymphoma patientsM Benekli, T Hahn, F Shafi, et al.
Journal of B.U.ON. : Official Journal of the Balkan Union of Oncology|June 16, 2011
Mitomycin-C in combination with fluoropyrimidines in the treatment of metastatic colorectal cancer after oxaliplatin and irinotecan failureN Alkis, U Demirci, M Benekli, et al.
Bone Marrow Transplantation|January 25, 2005
A prognostic model for prolonged event-free survival after autologous or allogeneic blood or marrow transplantation for relapsed and refractory Hodgkin's diseaseT Hahn, M Benekli, C Wong, et al.
Journal of B.U.ON. : Official Journal of the Balkan Union of Oncology|April 21, 2012
Prognostic factors in patients with advanced pancreatic cancer treated with gemcitabine alone or gemcitabine plus cisplatin: retrospective analysis of a multicenter studyA Inal, F T Kos, E Algin, et al.
Pageof 7

Showing results (51-60 of 61) with videos related to

Sort By:
Pageof 7
Journal of B.U.ON. : Official Journal of the Balkan Union of Oncology|July 27, 2010
Efficacy and toxicity of preoperative chemotherapy with docetaxel and epirubicin in locally advanced invasive breast cancerA O Kaya, U Coskun, S Buyukberber, et al.
Bone Marrow Transplantation|December 12, 2007
Intensive conditioning regimen of etoposide (VP-16), cyclophosphamide and carmustine (VCB) followed by autologous hematopoietic stem cell transplantation for relapsed and refractory Hodgkin's lymphomaM Benekli, S L Smiley, T Younis, et al.
Breast (Edinburgh, Scotland)|August 20, 2013
Phase II study of lapatinib in combination with vinorelbine in patients with HER2 positive recurrent or metastatic breast cancer: a multicentric Turkish Oncology Group (TOG) trialP Saip, Y Eralp, F Sen, et al.
Neoplasma|January 15, 2008
Xelox (capecitabine plus oxaliplatin) as neoadjuvant chemotherapy of unresectable liver metastases in colorectal cancer patientsU Coskun, S Buyukberber, E Yaman, et al.
Neoplasma|November 23, 2011
Gemcitabine and cisplatin combination chemotherapy in triple negative metastatic breast cancer previously treated with a taxane/anthracycline chemotherapy; multicenter experienceM Ozkan, V Berk, M A Kaplan, et al.
Journal of B.U.ON. : Official Journal of the Balkan Union of Oncology|January 22, 2013
Multiple primary malignant neoplasms: multi-center results from TurkeyN A Babacan, S Aksoy, B Cetin, et al.
Bone Marrow Transplantation|July 3, 2003
Effect of rituximab on peripheral blood stem cell mobilization and engraftment kinetics in non-Hodgkin's lymphoma patientsM Benekli, T Hahn, F Shafi, et al.
Journal of B.U.ON. : Official Journal of the Balkan Union of Oncology|June 16, 2011
Mitomycin-C in combination with fluoropyrimidines in the treatment of metastatic colorectal cancer after oxaliplatin and irinotecan failureN Alkis, U Demirci, M Benekli, et al.
Bone Marrow Transplantation|January 25, 2005
A prognostic model for prolonged event-free survival after autologous or allogeneic blood or marrow transplantation for relapsed and refractory Hodgkin's diseaseT Hahn, M Benekli, C Wong, et al.
Journal of B.U.ON. : Official Journal of the Balkan Union of Oncology|April 21, 2012
Prognostic factors in patients with advanced pancreatic cancer treated with gemcitabine alone or gemcitabine plus cisplatin: retrospective analysis of a multicenter studyA Inal, F T Kos, E Algin, et al.
Pageof 7